Cited by 548Coronary Interventions and DiagnosticsAtherosclerosis and Cardiovascular DiseasesCerebrovascular and Carotid Artery Diseases

Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis

Yahagi, Kazuyuki, Kolodgie, Frank D., Otsuka, Fumiyuki, Finn, Aloke V., Davis, Harry R., Joner, Michael, Virmani, Renu·2016·Nature Reviews Cardiology

Abstract

Plaque rupture, usually of a precursor lesion known as a 'vulnerable plaque' or 'thin-cap fibroatheroma', is the leading cause of thrombosis. Less-frequent aetiologies of coronary thrombosis are erosion, observed with greatest incidence in women aged <50 years, and eruptive calcified nodules, which are occasionally identified in older individuals. Various treatments for patients with coronary artery disease, such as CABG surgery and interventional therapies, have led to accelerated atherosclerosis. These processes occur within months to years, compared with the decades that it generally takes for native disease to develop. Morphological identifiers of accelerated atherosclerosis include macrophage-derived foam cells, intraplaque haemorrhage, and thin fibrous cap. Foam-cell infiltration can be observed within 1 year of a saphenous vein graft implantation, with subsequent necrotic core formation and rupture ensuing after 7 years in over one-third of patients. Neoatherosclerosis occurs early and with greater prevalence in drug-eluting stents than in bare-metal stents and, although rare, complications of late stent thrombosis from rupture are associated with high mortality. Comparison of lesion progression in native atherosclerotic disease, atherosclerosis in saphenous vein grafts, and in-stent neoatherosclerosis provides insight into the pathogenesis of atheroma formation in natural and iatrogenic settings.

Integrity signals

Registry

Crossref · 10.1038/nrcardio.2015.164

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies of plaque histology from human autopsy tissues have culminated in a scheme for classification of plaques that encapsulates the progression of atherosclerosis.

    “Studies of plaque histology from human autopsy tissues have culminated in a scheme for classification of plaques that encapsulates the progression of atherosclerosis 88,89 and, based on careful observations of plaque composition from human autopsy and animal models, it is clear that VSMCs are major contributors to plaque development at all stages (summarised in FIG. 1).”

    From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [89]

  • Based on careful observations of plaque composition from human autopsy and animal models, VSMCs are major contributors to plaque development at all stages.

    “Studies of plaque histology from human autopsy tissues have culminated in a scheme for classification of plaques that encapsulates the progression of atherosclerosis 88,89 and, based on careful observations of plaque composition from human autopsy and animal models, it is clear that VSMCs are major contributors to plaque development at all stages (summarised in FIG. 1).”

    From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [89]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yahagi, K., Kolodgie, F. D., Otsuka, F., Finn, A. V., Davis, H. R., Joner, M., & Virmani, R.
Affiliations
  • CVPath Institute (US)
  • Emory University Hospital (US)
Corresponding author
Virmani, Renu
Venue
Nature Reviews Cardiology
Published
2015-10-27
Volume
13
Issue
2
Pages
79-98
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
OpenAlex
W2264045234
Cited by
548
References
122
Citations by year
2026: 29 · 2025: 41 · 2024: 70 · 2023: 56 · 2022: 62 · 2021: 59 · 2020: 70 · 2019: 50 · 2018: 49 · 2017: 36 · 2016: 24
FWCI
6.96
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK094434)
Topics
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords
coronary artery disease, vein graft atherosclerosis, in-stent neoatherosclerosis, premature atherosclerosis, atherosclerotic plaque morphology, plaque rupture, vulnerable plaque, thin-cap fibroatheroma, coronary thrombosis, plaque erosion, saphenous vein graft, drug-eluting stents, bare-metal stents, stent thrombosis, intraplaque hemorrhage, foam cells
MeSH terms
Coronary Artery Bypass, Coronary Artery Disease, Humans, Saphenous Vein, United States, Incidence, Prevalence, Survival Rate, Disease Progression, Coronary Restenosis, Drug-Eluting Stents, Plaque, Atherosclerotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review